Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study

Ditte-Marie Bretler, Peter Riis Hansen, Steen Zabell Abildstrøm, Casper Haslund Jørgensen, Rikke Sørensen, Morten Lock Hansen, Tina Ken Schramm, Ellen Løkkegaard, Christian Torp-Pedersen, Gunnar Hilmar Gislason

9 Citationer (Scopus)

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: General use of hormone replacement therapy (HRT) dropped drastically after 2002 when pivotal randomized trials showed increased risk of coronary artery disease and other complications with HRT. HRT is not recommended for primary or secondary prevention of coronary heart disease and guidelines recommend discontinuation of HRT after myocardial infarction (MI). It is unknown whether women actually discontinue HRT after MI.
OriginalsprogEngelsk
TidsskriftBritish Journal of Clinical Pharmacology
Vol/bind71
Udgave nummer1
Sider (fra-til)105-15
Antal sider11
ISSN0306-5251
DOI
StatusUdgivet - 1 jan. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study'. Sammen danner de et unikt fingeraftryk.

Citationsformater